Research and Development
NICE recommends mirikizumab (Omvoh โผ) for previously treated moderately to severely active Crohn’s disease 1
May 30, 2025 Research and Development Crohnโs disease, Eli Lilly and Company, Gastrointestinal tract, Medicines and Healthcare products Regulatory Agency (MHRA)(, NHS England and Wales, National Institute for Health and Care Excellence (NICE), Omvoh, inflammatory bowel disease (IBD), mirikizumab
DEBRA Research and Dermaliq Therapeutics collaborate to advance treatment for rare skin disorder
May 29, 2025 Research and Development DEBRA Research, Dermaliq Therapeutics, Dermatology, epidermolysis bullosa, non-profit organisation, skin disorders
Ryvu Therapeutics appoints Justyna ลปรณลtek to management board
May 29, 2025 Medical Communications, Research and Development Oncology, Ryvu Therapeutics, chief people officer, human resources, management board, oncology
Neogap receives approval to administer full dose in cell therapy trial for colorectal cancer
May 28, 2025 Research and Development Neogap, Oncology, Swedish Medical Products Agency, colorectal cancer
UK Researcher Wins Prestigious IBSA Foundation Fellowship for Pioneering Dermatology Study
May 28, 2025 Medical Communications, Research and Development Dermatology, IBSA Foundation Fellowship, Institut Biochimique SA (IBSA), Masami Ando Kuri, Milan Italy, Wellcome Sanger Institute, dermatology
The Royal Marsden launches AI radiology platform to revolutionise cancer care
May 27, 2025 Analytical & Laboratory Services, Market & Product Development, Medical Education, Research and Development AI, CARPL.ai., Institute of Cancer Research, NTT DATA, National Institute for Health and Care Research, Oncology, The Royal Marsden, oncology, radiology
MC2 Therapeutics appoints Trine Ahlgreen as new CEO
May 27, 2025 Research and Development, Sales and Marketing CEO, Corporate, MC2 Therapeutics, Skin, inflammatory skin conditions
Moderna doses first US patient in phase 1 trial of mRNA-4106 for solid tumours
May 23, 2025 Research and Development Moderna, Oncology, START Center for Cancer Research, US
NICE recommends treatment for chronic kidney disease, IgA nephropathy
May 23, 2025 Market & Product Development, Medical Communications, Research and Development IgA nephropathy, National Institute for Health and Care Excellence, Nephrology, kidney disease
CHMP issues positive opinion for Blenrep combinations in relapsed/refractory multiple myeloma
May 23, 2025 Market & Product Development, Medical Communications, Research and Development Blenrep, Committee for Medicinal Products for Human USE, European Medicines Agency, Oncology, multiple myeloma
Sanofi to acquire Vigil Neuroscience, adding Alzheimerโs disease candidate to early-stage pipeline
May 23, 2025 Mergers and Acquisitions, Research and Development Alzheimer's disease, Neurology, Sanofi, Vigil Neuroscience, neurodegenerative diseases
PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media
May 23, 2025 Research and Development Animal-Free, Artificial Human Platelets, Corporate, DewCell, Haematology, Human Platelet Lysate, Letter of Intent, Oncology, PL Bioscience
Another Day Pharma announces successful Phase II trial results for BZ371A in post-prostatectomy erectile dysfunctionย
May 22, 2025 Research and Development Another Day Pharma, Genito-Urinary system, clinical trial, erectile dysfunction, prostate cancer, prostatectomy
Tiakis Biotech appoints Christoph Schmidt to supervisory board
May 22, 2025 Research and Development Cardiology, Tiakis Biotech, cardiovascular diseases, pulmonary arterial hypertension
NICE recommends Pfizerโs new once-weekly treatment for haemophilia B on NHS
May 22, 2025 Market Access, Research and Development Haematology, Hympavzi, NHS, NICE, Pfizer, haemophilia B, marstacimab
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
